Apex Biotechnology Corp. (1733.TW)
TWD 29.0
(2.29%)
TWD 29.0
(2.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 230.39 Million | 26.61 Million | 179.86 Million | 280.6 Million | 462.52 Million | 67.56 Million |
| Net Income | 140.96 Million | 199.57 Million | 184.93 Million | 110.61 Million | 162.94 Million | 161.34 Million |
| Depreciation & Amortization | 75.71 Million | 94.1 Million | 95.67 Million | 105.19 Million | 116.19 Million | 105.89 Million |
| Deferred income taxes | - | - | 3.59 Million | - | - | - |
| Stock-based compensation | - | - | 1.59 Million | - | - | - |
| Change in working capital | 4.49 Million | -239.01 Million | -119.21 Million | 76.3 Million | 176.55 Million | -267.19 Million |
| Other non-cash items | 9.22 Million | -28.04 Million | 13.28 Million | -11.51 Million | 6.82 Million | 67.52 Million |
| Investing Cash Flow | -22.49 Million | -41.36 Million | -35.01 Million | 78.82 Million | -132.82 Million | -45.34 Million |
| Investments in PPE | -24.97 Million | -40.2 Million | -26.19 Million | -48.32 Million | -56.58 Million | -75.28 Million |
| Acquisitions | 2.5 Million | - | -176.34 Million | 823 Thousand | -1.67 Million | 6.83 Million |
| Investment purchases | - | -1.7 Million | -1.99 Million | -275 Million | -484.75 Million | -606.24 Million |
| Sales/Maturities of investments | - | 1 Million | 176.34 Million | 398.18 Million | 408.14 Million | 636.47 Million |
| Other Investing Activities | -25 Thousand | -462 Thousand | -6.81 Million | 3.14 Million | 2.03 Million | -7.12 Million |
| Financing Cash Flow | -168.14 Million | -237.6 Million | -351.27 Million | -224.84 Million | 6.73 Million | -344.94 Million |
| Debt repayment | -301.15 Million | -1.06 Billion | -404.19 Million | -297.51 Million | -20 Million | -1.1 Billion |
| Dividends payments | -139.93 Million | -129.93 Million | -109.31 Million | -109.94 Million | -84.73 Million | -149.59 Million |
| Common Stock Repurchased | - | - | - | -12.24 Million | - | - |
| Common Stock Issuance | - | - | 12.24 Million | 194.49 Million | - | - |
| Other Financing Activities | 272.94 Million | 956.94 Million | 162.23 Million | 363 Thousand | 111.46 Million | 909.1 Million |
| Accounts receivables | 193.23 Million | 2.5 Million | -157.46 Million | 102.38 Million | 62.72 Million | -189.83 Million |
| Accounts payables | -96.22 Million | -59.5 Million | 99.3 Million | -30.54 Million | 41.35 Million | 22.33 Million |
| Inventory | -17.96 Million | -116.66 Million | -136.05 Million | -8.99 Million | 111.97 Million | -105.7 Million |
| Other working capital | -74.55 Million | -65.34 Million | 74.99 Million | 13.45 Million | -39.49 Million | -161.49 Million |
| Cash at beginning of period | 331.7 Million | 555.33 Million | 786.94 Million | 653.69 Million | 318.18 Million | 622.54 Million |
| Cash at end of period | 382.04 Million | 331.7 Million | 555.33 Million | 786.94 Million | 653.69 Million | 318.18 Million |
| Capital Expenditure | -24.97 Million | -40.2 Million | -26.19 Million | -48.32 Million | -56.58 Million | -75.28 Million |
| Effect of forex changes on cash | 10.58 Million | 28.72 Million | -25.18 Million | -1.33 Million | -917 Thousand | 18.36 Million |
| Net cash flow / Change in cash | 50.34 Million | -223.62 Million | -231.61 Million | 133.24 Million | 335.5 Million | -304.35 Million |
| Free Cash Flow | 205.41 Million | -13.58 Million | 153.66 Million | 232.27 Million | 405.94 Million | -7.72 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 27.28 Million | 29.14 Million | 140.96 Million | 12.34 Million | 48.47 Million | 33.52 Million |
| Depreciation & Amortization | 16.21 Million | 16.62 Million | 75.71 Million | 18.06 Million | 18.9 Million | 19.13 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 73.54 Million | -10.36 Million | 4.49 Million | 48.22 Million | -39.66 Million | 102.26 Million |
| Other non-cash items | -33.96 Million | 58.7 Million | 9.22 Million | 28.92 Million | 1.67 Million | -22.22 Million |
| Investing Cash Flow | -11.26 Million | -2.86 Million | -22.49 Million | -5.07 Million | -3.53 Million | -7.38 Million |
| Investments in PPE | -11.29 Million | -2.99 Million | -24.97 Million | -4.94 Million | -4.33 Million | -8.65 Million |
| Acquisitions | - | - | 2.5 Million | - | 800 Thousand | 1.19 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 38 Thousand | 136 Thousand | -25 Thousand | -128 Thousand | 800 Thousand | 73 Thousand |
| Financing Cash Flow | -114.1 Million | -22.06 Million | -168.14 Million | 28.12 Million | -142.27 Million | -41.81 Million |
| Debt repayment | -2.27 Million | -19.58 Million | -301.15 Million | -227 Thousand | -30.37 Million | -40.15 Million |
| Dividends payments | -109.94 Million | - | -139.93 Million | - | -139.93 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.88 Million | -27 Thousand | 272.94 Million | 28.34 Million | 28.03 Million | -1.65 Million |
| Accounts receivables | 2.2 Million | -76.92 Million | 193.23 Million | 47.69 Million | -11.99 Million | 96.77 Million |
| Accounts payables | 34.53 Million | 5.95 Million | -96.22 Million | 20.78 Million | -16.21 Million | -58.43 Million |
| Inventory | 2.26 Million | 45.28 Million | -17.96 Million | -3.91 Million | 19.51 Million | 9.17 Million |
| Other working capital | 34.53 Million | 15.31 Million | -74.55 Million | -16.34 Million | -30.96 Million | 54.73 Million |
| Cash at beginning of period | 397.82 Million | 382.04 Million | 331.7 Million | 251.97 Million | 365.41 Million | 276.83 Million |
| Cash at end of period | 365.14 Million | 397.82 Million | 382.04 Million | 382.04 Million | 251.97 Million | 365.41 Million |
| Capital Expenditure | -11.29 Million | -2.99 Million | -24.97 Million | -4.94 Million | -4.33 Million | -8.65 Million |
| Effect of forex changes on cash | 3 Million | 5.53 Million | 10.58 Million | -545 Thousand | 2.97 Million | 5.07 Million |
| Net cash flow / Change in cash | -32.68 Million | 15.77 Million | 50.34 Million | 130.06 Million | -113.43 Million | 88.57 Million |
| Free Cash Flow | 78.37 Million | 32.17 Million | 205.41 Million | 102.61 Million | 25.06 Million | 124.04 Million |
SPKKY
GLMFF
SOLARINDS
THEJO
DML
APARINDS